Location: 6001 Executive Blvd, Rockville, MD 20852 / Zoom
Despite substantial public and private interest in developing therapeutics for the Parkinson’s disease (PD) community, there persists separation between disease understanding and development of drugs to target these processes in Parkinson’s patients. The NINDS is convening a hybrid workshop with the overarching goal to (1) delineate what the crucial elements of those gaps are and (2) determine how to close those gaps as a community of stakeholders, including academic researchers, industry partners, non-profit organizations, and people with lived experience of Parkinson’s Disease.
This workshop is co-chaired by Alice Chen-Plotkin, MD, Parker Family Professor of Neurology, University of Pennsylvania School of Medicine and William Martin, PhD, Global Therapeutic Area Head, Neuroscience at Johnson & Johnson Innovative Medicine.
Full agenda and Registration available at https://event.roseliassociates.com/pdtherapeutics/.
For further information, please contact Neel Dhruv neel.dhruv@nih.gov